ciprofloxacin has been researched along with Gasser Syndrome in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of the 24 patients with EHEC-associated diarrhea, seven received antibiotics before any signs of HUS were present (ciprofloxacin, cefotaxime, amoxicillin and/or metronidazole)." | 7.79 | Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. ( Fritzsche, C; Geerdes-Fenge, HF; Henschel, J; Höhn, R; Koball, S; Löbermann, M; Mitzner, S; Nürnberg, M; Podbielski, A; Reisinger, EC; Schober, HC, 2013) |
| "To report the first case of ciprofloxacin-associated hemolytic-uremic syndrome (HUS)." | 7.71 | Ciprofloxacin-associated hemolytic-uremic syndrome. ( Allan, DS; Barr, RM; Chin-Yee, IH; Clark, WF; Thompson, CM, 2002) |
| "Of the 24 patients with EHEC-associated diarrhea, seven received antibiotics before any signs of HUS were present (ciprofloxacin, cefotaxime, amoxicillin and/or metronidazole)." | 3.79 | Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea. ( Fritzsche, C; Geerdes-Fenge, HF; Henschel, J; Höhn, R; Koball, S; Löbermann, M; Mitzner, S; Nürnberg, M; Podbielski, A; Reisinger, EC; Schober, HC, 2013) |
| "To report the first case of ciprofloxacin-associated hemolytic-uremic syndrome (HUS)." | 3.71 | Ciprofloxacin-associated hemolytic-uremic syndrome. ( Allan, DS; Barr, RM; Chin-Yee, IH; Clark, WF; Thompson, CM, 2002) |
| "Rifaximin has been evaluated in adults for treatment of bacterial enteritis and has a good record for safety and efficacy, but it has not been evaluated extensively in children with gastroenteritis." | 1.34 | Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. ( Chen, J; Cleary, TG; Gonzales, E; Ochoa, TJ; Walker, CM, 2007) |
| "The development of toxic megacolon as a complication of infectious colitis is rare." | 1.33 | Toxic megacolon complicating Escherichia coli O157 infection. ( Koerner, RJ; McElroy, J; Nayar, DM; Pai, P; Vetrivel, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ochoa, TJ | 1 |
| Chen, J | 1 |
| Walker, CM | 1 |
| Gonzales, E | 1 |
| Cleary, TG | 1 |
| Bauwens, A | 1 |
| Kunsmann, L | 1 |
| Karch, H | 1 |
| Mellmann, A | 1 |
| Bielaszewska, M | 1 |
| Yin, S | 1 |
| Rusconi, B | 1 |
| Sanjar, F | 1 |
| Goswami, K | 1 |
| Xiaoli, L | 1 |
| Eppinger, M | 1 |
| Dudley, EG | 1 |
| Geerdes-Fenge, HF | 1 |
| Löbermann, M | 1 |
| Nürnberg, M | 1 |
| Fritzsche, C | 1 |
| Koball, S | 1 |
| Henschel, J | 1 |
| Höhn, R | 1 |
| Schober, HC | 1 |
| Mitzner, S | 1 |
| Podbielski, A | 1 |
| Reisinger, EC | 1 |
| Jensen, C | 1 |
| Schiellerup, P | 1 |
| Olsen, K | 1 |
| Scheutz, F | 1 |
| Petersen, E | 1 |
| Gerner-Smidt, P | 1 |
| Mølbak, K | 1 |
| Nayar, DM | 1 |
| Vetrivel, S | 1 |
| McElroy, J | 1 |
| Pai, P | 1 |
| Koerner, RJ | 1 |
| Taneja, N | 1 |
| Lyngdoh, VW | 1 |
| Sharma, M | 1 |
| Kater, AP | 1 |
| Westermann, AM | 1 |
| de Groot, MR | 1 |
| von dem Borne, AE | 1 |
| Kuijper, EJ | 1 |
| Allan, DS | 1 |
| Thompson, CM | 1 |
| Barr, RM | 1 |
| Clark, WF | 1 |
| Chin-Yee, IH | 1 |
| O'Riordan, T | 1 |
| Kavanagh, P | 1 |
| Mellotte, G | 1 |
| Conneally, E | 1 |
| Mulvihill, E | 1 |
| Keogh, JA | 1 |
| Moráin, CO | 1 |
10 other studies available for ciprofloxacin and Gasser Syndrome
| Article | Year |
|---|---|
Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Topics: Anti-Infective Agents; Bacteriolysis; Child; Child, Preschool; Coliphages; Diarrhea; Escherichia col | 2007 |
Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.
Topics: Anti-Bacterial Agents; Cell Membrane Structures; Ciprofloxacin; Escherichia coli Infections; Escheri | 2017 |
Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phages.
Topics: Bacteriophages; Ciprofloxacin; Escherichia coli O157; Genome; Hemolytic-Uremic Syndrome; Humans; Pol | 2015 |
Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciproflo | 2013 |
Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study.
Topics: Adult; Ampicillin; Anti-Infective Agents; Carrier State; Child, Preschool; Ciprofloxacin; Denmark; E | 2005 |
Toxic megacolon complicating Escherichia coli O157 infection.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Colitis; Colon; Escherichia coli | 2006 |
Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacil | 2005 |
Toxin-mediated haemolytic uraemic syndrome without diarrhoea.
Topics: Anti-Infective Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Hemolytic-Uremi | 2000 |
Ciprofloxacin-associated hemolytic-uremic syndrome.
Topics: Anti-Infective Agents; Ciprofloxacin; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Precurso | 2002 |
Haemolytic uraemic syndrome with shigella.
Topics: Cefuroxime; Ciprofloxacin; Diagnosis, Differential; Dysentery, Bacillary; Fluid Therapy; Hemolytic-U | 1990 |